本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.72
-0.0600-3.37%
盤後1.740.0200+1.16%19:50 EDT
成交量:313.85萬
成交額:543.75萬
市值:5.93億
市盈率:-2.64
高:1.80
開:1.80
低:1.71
收:1.78
52周最高:4.46
52周最低:1.04
股本:3.45億
流通股本:2.62億
量比:0.49
換手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
淨資產收益率:-42.39%
總資產收益率:-22.08%
市淨率:1.36
市盈率(LYR):-1.99

資料載入中...

2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/10/04

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/20

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/09/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/09

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/16

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/16

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/15

重要事件披露

8-K - Current report
2021/05/20

重要事件披露

8-K - Current report
2021/05/19

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/05

重要事件披露

8-K - Current report